DK0789716T3 - Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h - Google Patents

Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h

Info

Publication number
DK0789716T3
DK0789716T3 DK95936566T DK95936566T DK0789716T3 DK 0789716 T3 DK0789716 T3 DK 0789716T3 DK 95936566 T DK95936566 T DK 95936566T DK 95936566 T DK95936566 T DK 95936566T DK 0789716 T3 DK0789716 T3 DK 0789716T3
Authority
DK
Denmark
Prior art keywords
allogeneic
antibodies
diagnosis
therapy
determining
Prior art date
Application number
DK95936566T
Other languages
English (en)
Inventor
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Application granted granted Critical
Publication of DK0789716T3 publication Critical patent/DK0789716T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95936566T 1994-11-04 1995-10-30 Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h DK0789716T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002238A IT1276860B1 (it) 1994-11-04 1994-11-04 Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
PCT/EP1995/004239 WO1996014340A1 (en) 1994-11-04 1995-10-30 Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for the determination thereof

Publications (1)

Publication Number Publication Date
DK0789716T3 true DK0789716T3 (da) 2000-10-09

Family

ID=11369803

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95936566T DK0789716T3 (da) 1994-11-04 1995-10-30 Antistoffer mod allogene og xenogene proteiner, deres anvendelse ved diagnose og terapi og fremgangsmåder til bestemmelse h

Country Status (26)

Country Link
EP (1) EP0789716B1 (da)
JP (1) JPH10508591A (da)
KR (1) KR100426029B1 (da)
CN (1) CN1046737C (da)
AR (1) AR002243A1 (da)
AT (1) ATE192166T1 (da)
AU (1) AU690756B2 (da)
BR (1) BR9509556A (da)
CA (1) CA2204380A1 (da)
CZ (1) CZ288322B6 (da)
DE (1) DE69516534T2 (da)
DK (1) DK0789716T3 (da)
ES (1) ES2147617T3 (da)
FI (1) FI971879L (da)
GR (1) GR3033956T3 (da)
HU (1) HUT76880A (da)
IL (1) IL115862A (da)
IT (1) IT1276860B1 (da)
NO (1) NO972046L (da)
NZ (1) NZ295171A (da)
PL (1) PL181115B1 (da)
PT (1) PT789716E (da)
RU (1) RU2160445C2 (da)
TR (1) TR199501353A2 (da)
WO (1) WO1996014340A1 (da)
ZA (1) ZA959255B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283634B1 (it) * 1996-05-10 1998-04-23 Zetesis Spa Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
CN100516876C (zh) * 2002-11-21 2009-07-22 惠氏公司 用于诊断肾细胞癌(rcc)和其他实体瘤的方法
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
IT201900022203A1 (it) * 2019-11-26 2021-05-26 Cusani Alberto Bartorelli Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
SU1603301A1 (ru) * 1987-12-22 1990-10-30 Карагандинский государственный медицинский институт Способ определени концентрации иммуноглобулинов в биологической жидкости
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.

Also Published As

Publication number Publication date
PL181115B1 (pl) 2001-05-31
FI971879A7 (fi) 1997-06-24
CN1046737C (zh) 1999-11-24
AU3845395A (en) 1996-05-31
AR002243A1 (es) 1998-03-11
EP0789716B1 (en) 2000-04-26
NZ295171A (en) 1998-07-28
EP0789716A1 (en) 1997-08-20
PT789716E (pt) 2000-09-29
TR199501353A2 (tr) 1996-06-21
DE69516534D1 (de) 2000-05-31
MX9703191A (es) 1997-07-31
NO972046D0 (no) 1997-05-02
CZ288322B6 (en) 2001-05-16
GR3033956T3 (en) 2000-11-30
IL115862A0 (en) 1996-01-31
AU690756B2 (en) 1998-04-30
CA2204380A1 (en) 1996-05-17
NO972046L (no) 1997-05-02
ATE192166T1 (de) 2000-05-15
ITMI942238A1 (it) 1996-05-04
KR100426029B1 (ko) 2004-07-31
ZA959255B (en) 1996-05-29
DE69516534T2 (de) 2000-11-30
BR9509556A (pt) 1997-09-16
IL115862A (en) 2001-06-14
RU2160445C2 (ru) 2000-12-10
CN1166838A (zh) 1997-12-03
CZ131497A3 (en) 1997-12-17
ITMI942238A0 (it) 1994-11-04
PL319878A1 (en) 1997-09-01
JPH10508591A (ja) 1998-08-25
HUT76880A (en) 1997-12-29
WO1996014340A1 (en) 1996-05-17
FI971879A0 (fi) 1997-05-02
IT1276860B1 (it) 1997-11-03
KR970707161A (ko) 1997-12-01
ES2147617T3 (es) 2000-09-16
FI971879L (fi) 1997-06-24

Similar Documents

Publication Publication Date Title
EE04377B1 (et) Kehakaalu modulaatorid, neile vastavad nukleiinhapped ja valgud ning nende kasutamine diagnostikas ja teraapias
FI952131A7 (fi) Analyysijärjestelmä potilaan verestä analysoitavan aineen tarkkailemiseksi
DE69532639D1 (de) Medizinische abbildung durch akkustische mittel
DK1818343T3 (da) Antistoffer mod humant IL-12
DK40484D0 (da) Polysaccharid/protein-konjugat,fremgangsmaade til fremstilling deraf og dets anvendelse i en vaccine
EP2141243A3 (en) Protein scaffolds for antibody mimics and other binding proteins
IS2505B (is) Speglunarskuggaefni, sem helst lengi í blóði, til sjúkdómsgreininga
FI963101L (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
ID18741A (id) Zat nikotinat dalam terapi
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
FR2766192B1 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
DK1012181T3 (da) Overfladeantigener og proteiner, der er nyttige i præparater til diagnose og forebyggelse af Lymes sygdom
PT946873E (pt) Metodos para diagnostico da aspergilose broncopulmonar alergica
FI840611A7 (fi) Taudinmääritysaine, menetelmä sen valmistamiseksi ja sen käyttö taudinmääritysmenetelmissä.
FI850051A7 (fi) Virusantigeeni, menetelmä sen talteenottamiseksi ja käyttämiseksi diag noosissa ja terapiassa.
FI883351A7 (fi) Diagnostinen menetelmä häiriöiden toteamiseksi RNA-aasi L:ssä
NO972046D0 (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
DK482989D0 (da) Apparat til brug ved ultralydundersoegelse
IT1279079B1 (it) Vibratore,in particolare per laboratorio dentistico
FI972055A7 (fi) Syljen analysointimenetelmä
IT1274006B (it) Saggio immunologico per analiti in campioni, che utilizza agenti alchilanti
FI903964A7 (fi) Menetelmä vasta-aineiden havaitsemiseksi verestä, ja menetelmässä käyt ettävä membraaniliuska ja membraanikalusto
NO990303L (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
IT1285523B1 (it) Laccasi modificata metodo per la sua preparazione e suo impiego nel settore alimentare
NO903222D0 (no) Diagnostiske maalinger og deres anvendelse ved bestemmelseav kliniske tilstander.